Events

The agenda for this symposium reflects the multidisciplinary nature of our membership. The presentations will focus on individualizing breast cancer risk assessment. With the recent progress in our understanding of the biology and therapeutics we are better able to personalize multidisciplinary treatment delivery with the goal of improving breast cancer outcomes. We are honored to have nationally renowned speakers addressing some of the most controversial aspects in the management of breast cancer. The morning session will cover a range of topics including an update on Level I evidence on invasive cancer, improved pathologic evaluation of disease, review of clinical trials data that furthers our understanding of the biology of ductal carcinoma in situ. The afternoon session includes an outstanding multidisciplinary faculty that will address various aspects of the management of triple negative breast cancer using a case-based format.

Advances in molecular imaging have led to the development of imaging biomarkers with tremendous potential to characterize cancer phenotype and therefore be useful as pharmacodynamic, predictive or prognostic biomarkers. These biomarkers, initially developed in pre-clinical testing ("the bench") not only face hurdles in initial clinical trials that may on occasion need further pre-clinical development. Moreover, the path from Phase 0 or Phase 1 trials to eventual pivotal studies that lead to regulatory approval requires elucidation particularly for imaging biomarkers. This overview will suggest development paradigms for imaging biomarkers, focusing on a specific biomarker and highlighting translational and relevant regulatory features.

This paper will outline the components of the best and worst of Civil War medicine, and argue that the conditions in southern hospitals were so far inferior to those of the north that it probably made a difference to the war effort.

Join NYAM Fellows from the section on Anesthesiology, and other anesthesiologists from the New York area for dinner and an interactive oral board review. With leaders in the anesthesiology practice and research, our goal is to expose our residents in training and practitioner colleagues to the best in current and future anesthesiology practice, research, and teaching. In mock oral boards, the importance of organizational skills and test taking techniques will be discussed along with three exam related cases.

DASH-NY will host a webinar for NYSDOH contractors and significant partners about cultivating relationships with policymakers to sustain support for local prevention programs and the federal policy context for such programs. Webinar presenters will share strategies for educating elected officials that are appropriate and legal for non-profits and provide guidelines and key definitions for non-profits around lobbying and advocacy.

The NYAM on the History of Medicine and Public Health is pleased to announce the second Annual NYAM History Night meeting featuring NYAM Fellows and Members presenting on topics in the history of medicine and public health.

Genetics is rapidly enhancing our understanding and treatment of disease, but genetic testing presents ever new dilemmas for physicians and patients. In his new book, psychiatrist Robert Klitzman explores how individuals confront these complex issues in their daily lives.

The NYAM Section on Health Care Delivery presents a panel discussion on  the Community Benefit standard, the legal standard for determining whether a nonprofit hospital is exempt from federal income tax, moderated by Ellen Rautenberg, President and CEO of Public Health Solutions.